Trends in Pharmacological Sciences

Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?
pp. 195-197(3)
Authors: Di Marzo V.; Bifulco M.; De Petrocellis L.

Reply: a sanguine approach to cannabis
pp. 197-197(1)
Author: Baker D.

Schizophrenia, the dopamine hypothesis and ₂-adrenoceptor antagonists
pp. 198-199(2)
Author: Lindstrom L.H.

Maximal function of minimal K⁺ channel subunits
pp. 199-201(3)
Author: Sanguinetti M.C.

Central 5-HT_1A receptors and vagal tone to the airways
pp. 201-202(2)
Author: Ramage A.G.

Reply: 5-HT_1A receptors and control of airways
pp. 202-203(2)
Author: Cazzola M.

Anandamide and the question of its functional role for activation of capsaicin receptors
pp. 203-204(2)
Author: Szolcsanyi J.

Zinc and immunoresistance to infection in aging: new biological tools
pp. 205-208(4)
Authors: Mocchegiani E.; Muzzioli M.; Giacconi R.

The contribution of pharmacology to research on the mechanisms of memory formation
pp. 208-210(3)
Authors: McGaugh J.L.; Izquierdo I.

Erratum
pp. 210-210(1)
Author: Reed J.C.

Nicotinic receptor function: new perspectives from knockout mice
pp. 211-217(7)
Authors: Cordero-Erausquin M.; Marubio L.M.; Klink R.; Changeux J.-P.

The endocannabinoid system as a target for therapeutic drugs
pp. 218-224(7)
Authors: Piomelli D.; Giuffrida A.; Calignano A.; Rodrguez de Fonseca F.

Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?
pp. 225-230(6)
Authors: Rubino A.; Yellon D.M.

Better than Prozac? - Antisense Technology in the Central Nervous System, edited by R.A. Leslie et al.
pp. 230-231(2)
Author: Stein C.A.

Role of mitochondria in neurodegeneration - Mitochondrial Inhibitors and Neurodegenerative Disorders, edited by P.R. Sanberg et al.
pp. 232-232(1)
Author: Richter C.